L

LifeMD Inc
NASDAQ:LFMD

Watchlist Manager
LifeMD Inc
NASDAQ:LFMD
Watchlist
Price: 12.46 USD -1.89% Market Closed
Market Cap: 555.5m USD

Wall Street
Price Targets

LFMD Price Targets Summary
LifeMD Inc

Wall Street analysts forecast LFMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFMD is 12.5 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

Lowest
Price Target
8.08 USD
35% Downside
Average
Price Target
12.5 USD
0% Upside
Highest
Price Target
15.75 USD
26% Upside
LifeMD Inc Competitors:
Price Targets
4928
Noevir Holdings Co Ltd
8% Upside
192820
Cosmax Inc
5% Downside
4452
Kao Corp
13% Upside
BEI
Beiersdorf AG
25% Upside
4527
Rohto Pharmaceutical Co Ltd
47% Upside
EL
Estee Lauder Companies Inc
1% Upside
6630
Ya-Man Ltd
21% Downside
603605
Proya Cosmetics Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
LifeMD Inc

For the last 8 years the compound annual growth rate for LifeMD Inc's revenue is 59%. The projected CAGR for the next 3 years is 25%.

59%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
LifeMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
LifeMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFMD's stock price target?
Price Target
12.5 USD

According to Wall Street analysts, the average 1-year price target for LFMD is 12.5 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

What is LifeMD Inc's Revenue forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for LifeMD Inc's revenue is 59%. The projected CAGR for the next 3 years is 25%.

Back to Top